JPMORGAN CHASE & CO - INSMED INC ownership

INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 38 filers reported holding INSMED INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$428,845
-87.5%
431,000
-88.0%
0.00%
Q2 2023$3,421,049
+13.7%
3,603,000
+7.8%
0.00%
Q1 2023$3,008,000
+103911.1%
3,342,000
+7.0%
0.00%
Q4 2022$2,892
-99.9%
3,122,000
+40.3%
0.00%
Q3 2022$2,092,000
+286.7%
2,226,000
+279.2%
0.00%
Q2 2022$541,000
-88.9%
587,000
-87.9%
0.00%
-100.0%
Q1 2022$4,863,000
+124.5%
4,862,000
+131.0%
0.00%
Q4 2021$2,166,000
+104.9%
2,105,000
+106.2%
0.00%
Q3 2021$1,057,000
+81.3%
1,021,000
+95.6%
0.00%
Q1 2021$583,000
-71.4%
522,000
-70.8%
0.00%
Q4 2020$2,039,000
+367.7%
1,790,000
+297.8%
0.00%
Q4 2019$436,000450,0000.00%
Other shareholders
INSMED INC shareholders Q3 2021
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 2,974,000$2,536,0001.90%
Mohican Financial Management, LLC 500,000$422,0001.47%
LINDEN ADVISORS LP 51,146,000$43,311,0001.32%
ZAZOVE ASSOCIATES LLC 15,101,000$12,810,0001.11%
DLD Asset Management, LP 24,500,000$20,911,0001.03%
ADVENT CAPITAL MANAGEMENT /DE/ 31,749,000$26,863,0000.55%
Cheyne Capital Management (UK) LLP 1,000,000$853,0000.51%
SSI INVESTMENT MANAGEMENT LLC 6,000,000$5,050,0000.39%
Jabre Capital Partners S.A. 1,100,000$943,0000.31%
Orbimed Advisors 26,500,000$22,611,0000.27%
View complete list of INSMED INC shareholders